Which should you choose? Here's what you need to know.
Survodutide and Tesofensine are both weight loss (glp-1) peptides, but they work differently. A dual GLP-1/glucagon receptor agonist being developed by Boehringer Ingelheim for obesity and metabolic liver disease. A triple monoamine reuptake inhibitor originally developed for neurological conditions, now studied for significant weight loss effects. Compare vendor pricing and availability below.
On 20 Sep 2026 Peptide Compare tracked 16 vendors selling Survodutide, cheapest in stock $7.50 per mg at Eros Peptides, and 13 selling Tesofensine, cheapest $99.99 per mg at Umbrella Labs.
A dual GLP-1/glucagon receptor agonist being developed by Boehringer Ingelheim for obesity and metabolic liver disease.
A triple monoamine reuptake inhibitor originally developed for neurological conditions, now studied for significant weight loss effects.
Once you've decided which peptide fits your needs, here's how they compare on price and vendor options. Prices verified Sep 20, 2026.
Our top-rated vendor for each, based on trust scores, purity testing, and price.
Some outbound links may earn us a commission. Vendors cannot pay to improve rankings.
We re-check vendor prices continuously and score vendors on Finnrick blind-test results — samples bought anonymously and sent to a lab, not vendor claims. No vendor can pay to rank higher. See our full methodology.